United States

Products

In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second largest influenza vaccine company in the world. 

Product Description Additional info
Afluria®, Influenza Vaccine 
Important Safety Information
Prescribing Information
AFLURIA  is an inactivated (virus is not alive) influenza vaccine used for immunization against influenza disease caused by influenza virus subtypes A and B present in the vaccine.  Afluria website
     
Fluad, Influenza Vaccine, Adjuvanted
Important Safety Information
Prescribing Information
FLUAD is an activated influenza vaccine indicated for active immunization against influenza disease caused by influenza subtypes A and type B contained in the vaccine. Fluad website
     
Flucelvax®, Influenza Vaccine
Important Safety Information

Prescribing Information
FLUCELVAX is indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. Flucelvax website
     
Fluvirin®, Influenza Vaccine
Important Safety Information
Prescribing Information
FLUVIRIN is a trivalent, inactivated subunit influenza virus vaccine. Fluvirin website
     
Rapivab, Peramivir Injection
Important Safety Information
Prescribing Information
RAPIVAB is indicated for the treatment of acute uncomplicated influenza in patients 18 years and older who have been symptomatic for no more than 2 days. Rapivab website


Note: As we update our websites to reflect our new corporate identity, please be aware that you will continue to see bioCSL and Novartis branding in some areas until all regulatory requirements are completed.

 

The information presented on this site is intended for US residents only.
© 2017 Seqirus All rights reserved.
Seqirus is a trademark of CSL Limited.

BCSL14-02-0003 06/2014